Staccato Loxapine in Agitated Patients With Schizophrenia
NCT00628589
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
344
Enrollment
UNKNOWN
Sponsor class
Conditions
Patients With Schizophrenia and Acute Agitation
Interventions
DRUG:
Inhaled loxapine 5 mg
DRUG:
Inhaled loxapine 10 mg
DRUG:
Inhaled placebo
Sponsor
Alexza Pharmaceuticals, Inc.